The North America Ureteral Stents Market would witness market growth of 5.8% CAGR during the forecast period (2023-2030). In the year 2019, the North America market's volume surged to 3,479.8 thousand units, showcasing a growth of 5.5% (2019-2022).
These stents are pivotal in urology, offering critical solutions to various medical conditions affecting the urinary system. These tubular, malleable devices are specifically engineered to tackle obstacles associated with urinary flow by offering assistance and promoting the drainage of urine from the kidneys to the bladder. In recent years, the market has expanded due to a number of factors, including the rising incidence of urological disorders, developments in medical technology, and the aging of the population.
Additionally, the adoption of these stents has become widespread in diagnostic and therapeutic contexts. Urologists, nephrologists, and other healthcare professionals routinely deploy these devices to manage various conditions affecting the urinary tract. The stents are commonly employed for diagnostic purposes in suspected or confirmed ureteral obstruction cases. By placing a stent, healthcare professionals can assess the degree and location of the obstruction, helping to guide further diagnostic and treatment decisions. The versatility of these stents has contributed to their widespread adoption, with applications ranging from alleviating urinary obstructions to post-surgical management and treating kidney stones.
North America, including the United States and Canada, has been experiencing a demographic shift towards an older population. This is characterized by a larger proportion of people aged 65 and older compared to younger age groups. Canada's population is growing, and it is also aging. To meet the needs of a growing and aging population, there is a need to construct and renovate healthcare facilities. In 2023, the government of Canada invested over $198 billion to help improve the healthcare system. Therefore, the growing elderly population in North America is expected to boost the demand for these stents in the region.
The US market dominated the North America Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $213.2 million by 2030. The Canada market is experiencing a CAGR of 8.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
These stents are pivotal in urology, offering critical solutions to various medical conditions affecting the urinary system. These tubular, malleable devices are specifically engineered to tackle obstacles associated with urinary flow by offering assistance and promoting the drainage of urine from the kidneys to the bladder. In recent years, the market has expanded due to a number of factors, including the rising incidence of urological disorders, developments in medical technology, and the aging of the population.
Additionally, the adoption of these stents has become widespread in diagnostic and therapeutic contexts. Urologists, nephrologists, and other healthcare professionals routinely deploy these devices to manage various conditions affecting the urinary tract. The stents are commonly employed for diagnostic purposes in suspected or confirmed ureteral obstruction cases. By placing a stent, healthcare professionals can assess the degree and location of the obstruction, helping to guide further diagnostic and treatment decisions. The versatility of these stents has contributed to their widespread adoption, with applications ranging from alleviating urinary obstructions to post-surgical management and treating kidney stones.
North America, including the United States and Canada, has been experiencing a demographic shift towards an older population. This is characterized by a larger proportion of people aged 65 and older compared to younger age groups. Canada's population is growing, and it is also aging. To meet the needs of a growing and aging population, there is a need to construct and renovate healthcare facilities. In 2023, the government of Canada invested over $198 billion to help improve the healthcare system. Therefore, the growing elderly population in North America is expected to boost the demand for these stents in the region.
The US market dominated the North America Ureteral Stents Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $213.2 million by 2030. The Canada market is experiencing a CAGR of 8.2% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 7.2% during (2023 - 2030).
Based on End User, the market is segmented into Hospitals, and Ambulatory Surgical Centers (ASCS) & Clinics. Based on Material, the market is segmented into Metallic Stents and Polymer Stents (Silicone Stents, Hybrid Stents, and Polyurethane Stents). Based on Product, the market is segmented into Double Pigtail Stent, Open/Closed Pigtail Stent, and Multiloop Stents. Based on Application, the market is segmented into Kidney Stones, Kidney Transplantation, Urinary Incontinence, Tumors, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Boston Scientific Corporation, B. Braun Melsungen AG, Coloplast Group, Medline Industries, Inc., Allium Ltd, Cook Medical, Inc. (Cook Group), Pnn Medical A/S, Teleflex, Inc., Olympus Corporation and Becton, Dickinson, and Company
Scope of the Study
Market Segments Covered in the Report:
By End User (Volume, Thousand Units, Revenue, USD Million, 2019-30)- Hospitals
- Ambulatory Surgical Centers (ASCS) & Clinics
- Metallic Stents
- Polymer Stents
- Silicone Ureteral Stents
- Hybrid Ureteral Stents
- Polyurethane Stents
- Double Pigtail Stent
- Open/Closed Pigtail Stent
- Multiloop Stents
- Kidney Stones
- Kidney Transplantation
- Urinary Incontinence
- Tumors
- Others
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Boston Scientific Corporation
- B.Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market At a Glance
Chapter 3. Market Overview
Chapter 4. North America Ureteral Stents Market by End User
Chapter 5. North America Ureteral Stents Market by Material
Chapter 6. North America Ureteral Stents Market by Product
Chapter 7. North America Ureteral Stents Market by Application
Chapter 8. North America Ureteral Stents Market by Country
Chapter 9. Company Profiles
Companies Mentioned
- Boston Scientific Corporation
- B. Braun Melsungen AG
- Coloplast Group
- Medline Industries, Inc.
- Allium Ltd
- Cook Medical, Inc. (Cook Group)
- Pnn Medical A/S
- Teleflex, Inc.
- Olympus Corporation
- Becton, Dickinson, and Company
Methodology
LOADING...
